These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22985435)

  • 1. Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes.
    Younis NN; Soran H; Pemberton P; Charlton-Menys V; Elseweidy MM; Durrington PN
    Clin Sci (Lond); 2013 Mar; 124(5):343-9. PubMed ID: 22985435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes.
    Younis NN; Soran H; Sharma R; Charlton-Menys V; Greenstein A; Elseweidy MM; Durrington PN
    Diab Vasc Dis Res; 2010 Oct; 7(4):289-95. PubMed ID: 20876207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of LDL and its subfractions to glycation.
    Soran H; Durrington PN
    Curr Opin Lipidol; 2011 Aug; 22(4):254-61. PubMed ID: 21734572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro.
    Younis N; Charlton-Menys V; Sharma R; Soran H; Durrington PN
    Atherosclerosis; 2009 Jan; 202(1):162-8. PubMed ID: 18511055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin-dependent diabetes: a stable isotope kinetic study.
    Duvillard L; Pont F; Florentin E; Galland-Jos C; Gambert P; Vergès B
    Eur J Clin Invest; 2000 Aug; 30(8):685-94. PubMed ID: 10964160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HMG-CoA reductase with cerivastatin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus.
    Scharnagl H; Winkler K; Mantz S; Baumstark MW; Wieland H; März W
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):269-77. PubMed ID: 15146374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study.
    Idris I; Tate H; Ahmad A; McCormack T
    J Clin Lipidol; 2011; 5(4):316-23. PubMed ID: 21784378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The HMG-CoA reductase inhibitor cerivastatin lowers advanced glycation end products in patients with type 2 diabetes.
    Scharnagl H; Stojakovic T; Winkler K; Rosinger S; März W; Boehm BO
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):372-5. PubMed ID: 17701882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.
    Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS
    Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma protein lipofuscin-like fluorophores in men with coronary artery disease treated with statins.
    Sutherland WH; Williams MJ; de Jong SA
    Arch Med Res; 2007 Oct; 38(7):757-63. PubMed ID: 17845895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialic acids and the metabolism of low density lipoprotein.
    Melajärvi N; Gylling H; Miettinen TA
    J Lipid Res; 1996 Aug; 37(8):1625-31. PubMed ID: 8864946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
    Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
    Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC; Otto C; Parhofer KG
    Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small dense LDL cholesterol is a robust therapeutic marker of statin treatment in patients with acute coronary syndrome and metabolic syndrome.
    Fukushima Y; Hirayama S; Ueno T; Dohi T; Miyazaki T; Ohmura H; Mokuno H; Miyauchi K; Miida T; Daida H
    Clin Chim Acta; 2011 Jul; 412(15-16):1423-7. PubMed ID: 21530500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
    Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins do not decrease small, dense low-density lipoprotein.
    Choi CU; Seo HS; Lee EM; Shin SY; Choi UJ; Na JO; Lim HE; Kim JW; Kim EJ; Rha SW; Park CG; Oh DJ
    Tex Heart Inst J; 2010; 37(4):421-8. PubMed ID: 20844614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction.
    Lund-Katz S; Laplaud PM; Phillips MC; Chapman MJ
    Biochemistry; 1998 Sep; 37(37):12867-74. PubMed ID: 9737865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.